Piramal Pharma Limited Announces Results for Q4 and FY2024 [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
its standalone and consolidated results for the Fourth Quarter (Q4) and Full Year (FY) ended 31 st March 2024 Consolidated Financial Highlights (In INR Crores) Particulars Q4 FY24 Q4 FY23 YoY Growth FY24 FY23 YoY Growth Revenue from Operations 18 % 15 % CDMO 29 % 19 % Complex Hospital Generic (CHG) (5) % 7 % India Consumer Healthcare (ICH) 14 % 13 % EBITDA 48 % 61 % EBITDA Margin 22 % 17 % 17 % 12 % PAT (before exceptional item) 163 % NA Exceptional Item* NA NA PAT (after exceptional item) 102 % NA # FY2023 EBITDA had one-time inventory margin impact of INR 68 Crores * Q4 FY24 Exceptional item of INR 31 Crores towards non-cash write down of investment and license rights in relation to a certain third-party product no longer being commercialized Key Highlights for Q4 and FY2024 Revenue from Operations grew by 18% YoY and 15% YoY in Q4FY24 and FY24 respectively, driven by healthy growth in our
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Avenacy Announces Launch of Isoproterenol Hydrochloride Injection, USP in the U.S. Market [Yahoo! Finance]Yahoo! Finance
- Regulatory Information Management System Market Report 2024-2030: Increasing Adoption of Centralized RIMS among the Pharmaceutical and Medical Device Industry - A USD 4.12 Billion Market by 2030 [Yahoo! Finance]Yahoo! Finance
- Asembia Brings Together Top Pharmacy Executives for 20th Summit; Hosting Cornerstone Conference Delivering Continued Collaboration and Connections [Yahoo! Finance]Yahoo! Finance
- CeraVe Expands Sun Safety Day Initiative, Offering SPF Education From Coast to Coast This Summer [Yahoo! Finance]Yahoo! Finance
- Leading Penang-based Healthcare Provider Bags Multiple Awards at the GlobalHealth Asia-Pacific Awards 2024 [Yahoo! Finance Canada]Yahoo! Finance Canada
IQV
Earnings
- 5/2/24 - Beat
IQV
Sec Filings
- 5/17/24 - Form 3
- 5/10/24 - Form 8-K
- 5/9/24 - Form 4
- IQV's page on the SEC website